G

GLG Pharma

5 employees

GLG Pharma Personalized Medicine for Oncology using STAT3 inhibitors and novel cancer culture called Gx-C3

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Cancer cell growth inhibition with p-STAT3 blockers
CLL
GIST
FDA
Lung Cancer
STAT3
STAT3 diagnostic
Triple Negative Breast Cancer
Pharmaceutical
Breast Cancer
Ovarian Cancer
Health Care
Glioma
Repurposed drug GLG-801

Date founded

2009

Funding rounds raised

G

GLG Pharma raised undisclosed on October 16, 2012

Investors: Institute for Commercialization of Florida Technology

G

GLG Pharma raised undisclosed on May 10, 2012

Investors: Institute for Commercialization of Florida Technology

FAQ